List of Tables
Table 1. Global Cardiac-on-a-Chip Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Cardiac-on-a-Chip Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Cardiac-on-a-Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Cardiac-on-a-Chip Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Cardiac-on-a-Chip Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Cardiac-on-a-Chip Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Cardiac-on-a-Chip Sales by Region (2020-2025) & (K Units)
Table 8. Global Cardiac-on-a-Chip Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Cardiac-on-a-Chip Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Cardiac-on-a-Chip Sales Share by Manufacturers (2020-2025)
Table 12. Global Cardiac-on-a-Chip Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Cardiac-on-a-Chip Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Cardiac-on-a-Chip by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac-on-a-Chip as of 2024)
Table 16. Global Cardiac-on-a-Chip Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Cardiac-on-a-Chip Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Cardiac-on-a-Chip Manufacturing Base and Headquarters
Table 19. Global Cardiac-on-a-Chip Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Cardiac-on-a-Chip Sales by Type (2020-2025) & (K Units)
Table 23. Global Cardiac-on-a-Chip Sales by Type (2026-2031) & (K Units)
Table 24. Global Cardiac-on-a-Chip Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Cardiac-on-a-Chip Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Cardiac-on-a-Chip ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Cardiac-on-a-Chip Sales by Application (2020-2025) & (K Units)
Table 29. Global Cardiac-on-a-Chip Sales by Application (2026-2031) & (K Units)
Table 30. Cardiac-on-a-Chip High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Cardiac-on-a-Chip Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Cardiac-on-a-Chip Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Cardiac-on-a-Chip ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Cardiac-on-a-Chip Growth Accelerators and Market Barriers
Table 37. North America Cardiac-on-a-Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Cardiac-on-a-Chip Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Cardiac-on-a-Chip Growth Accelerators and Market Barriers
Table 40. Europe Cardiac-on-a-Chip Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Cardiac-on-a-Chip Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Cardiac-on-a-Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Cardiac-on-a-Chip Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Cardiac-on-a-Chip Growth Accelerators and Market Barriers
Table 45. Southeast Asia Cardiac-on-a-Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Cardiac-on-a-Chip Investment Opportunities and Key Challenges
Table 47. Central and South America Cardiac-on-a-Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Cardiac-on-a-Chip Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Cardiac-on-a-Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Emulate Corporation Information
Table 51. Emulate Description and Major Businesses
Table 52. Emulate Product Models, Descriptions and Specifications
Table 53. Emulate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Emulate Sales Value Proportion by Product in 2024
Table 55. Emulate Sales Value Proportion by Application in 2024
Table 56. Emulate Sales Value Proportion by Geographic Area in 2024
Table 57. Emulate Cardiac-on-a-Chip SWOT Analysis
Table 58. Emulate Recent Developments
Table 59. CN Bio Corporation Information
Table 60. CN Bio Description and Major Businesses
Table 61. CN Bio Product Models, Descriptions and Specifications
Table 62. CN Bio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. CN Bio Sales Value Proportion by Product in 2024
Table 64. CN Bio Sales Value Proportion by Application in 2024
Table 65. CN Bio Sales Value Proportion by Geographic Area in 2024
Table 66. CN Bio Cardiac-on-a-Chip SWOT Analysis
Table 67. CN Bio Recent Developments
Table 68. TissUse Corporation Information
Table 69. TissUse Description and Major Businesses
Table 70. TissUse Product Models, Descriptions and Specifications
Table 71. TissUse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. TissUse Sales Value Proportion by Product in 2024
Table 73. TissUse Sales Value Proportion by Application in 2024
Table 74. TissUse Sales Value Proportion by Geographic Area in 2024
Table 75. TissUse Cardiac-on-a-Chip SWOT Analysis
Table 76. TissUse Recent Developments
Table 77. Axion Biosystems Corporation Information
Table 78. Axion Biosystems Description and Major Businesses
Table 79. Axion Biosystems Product Models, Descriptions and Specifications
Table 80. Axion Biosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Axion Biosystems Sales Value Proportion by Product in 2024
Table 82. Axion Biosystems Sales Value Proportion by Application in 2024
Table 83. Axion Biosystems Sales Value Proportion by Geographic Area in 2024
Table 84. Axion Biosystems Cardiac-on-a-Chip SWOT Analysis
Table 85. Axion Biosystems Recent Developments
Table 86. Nortis Corporation Information
Table 87. Nortis Description and Major Businesses
Table 88. Nortis Product Models, Descriptions and Specifications
Table 89. Nortis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Nortis Sales Value Proportion by Product in 2024
Table 91. Nortis Sales Value Proportion by Application in 2024
Table 92. Nortis Sales Value Proportion by Geographic Area in 2024
Table 93. Nortis Cardiac-on-a-Chip SWOT Analysis
Table 94. Nortis Recent Developments
Table 95. InSphero Corporation Information
Table 96. InSphero Description and Major Businesses
Table 97. InSphero Product Models, Descriptions and Specifications
Table 98. InSphero Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. InSphero Recent Developments
Table 100. Mimetas Corporation Information
Table 101. Mimetas Description and Major Businesses
Table 102. Mimetas Product Models, Descriptions and Specifications
Table 103. Mimetas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Mimetas Recent Developments
Table 105. Ascendance Biotechnology Corporation Information
Table 106. Ascendance Biotechnology Description and Major Businesses
Table 107. Ascendance Biotechnology Product Models, Descriptions and Specifications
Table 108. Ascendance Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Ascendance Biotechnology Recent Developments
Table 110. Tara Biosystems Corporation Information
Table 111. Tara Biosystems Description and Major Businesses
Table 112. Tara Biosystems Product Models, Descriptions and Specifications
Table 113. Tara Biosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Tara Biosystems Recent Developments
Table 115. BioIVT Corporation Information
Table 116. BioIVT Description and Major Businesses
Table 117. BioIVT Product Models, Descriptions and Specifications
Table 118. BioIVT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. BioIVT Recent Developments
Table 120. Hesperos Corporation Information
Table 121. Hesperos Description and Major Businesses
Table 122. Hesperos Product Models, Descriptions and Specifications
Table 123. Hesperos Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Hesperos Recent Developments
Table 125. Zhejiang Ruiao Biotechnology Corporation Information
Table 126. Zhejiang Ruiao Biotechnology Description and Major Businesses
Table 127. Zhejiang Ruiao Biotechnology Product Models, Descriptions and Specifications
Table 128. Zhejiang Ruiao Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Zhejiang Ruiao Biotechnology Recent Developments
Table 130. BGI Genomics Corporation Information
Table 131. BGI Genomics Description and Major Businesses
Table 132. BGI Genomics Product Models, Descriptions and Specifications
Table 133. BGI Genomics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. BGI Genomics Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Cardiac-on-a-Chip Product Picture
Figure 2. Global Cardiac-on-a-Chip Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Myocardial Chip Product Picture
Figure 4. Heart Tissue Chip Product Picture
Figure 5. Cardiovascular Chip Product Picture
Figure 6. Global Cardiac-on-a-Chip Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Pharmaceutical R&D
Figure 8. Cardiovascular Disease Research
Figure 9. Clinical Diagnosis
Figure 10. Cardiac-on-a-Chip Report Years Considered
Figure 11. Global Cardiac-on-a-Chip Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 13. Global Cardiac-on-a-Chip Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Cardiac-on-a-Chip Revenue Market Share by Region (2020-2031)
Figure 15. Global Cardiac-on-a-Chip Sales (2020-2031) & (K Units)
Figure 16. Global Cardiac-on-a-Chip Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Cardiac-on-a-Chip Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Cardiac-on-a-Chip Sales Volume Market Share in 2024
Figure 19. Global Cardiac-on-a-Chip Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Myocardial Chip Revenue Market Share by Manufacturer in 2024
Figure 22. Heart Tissue Chip Revenue Market Share by Manufacturer in 2024
Figure 23. Cardiovascular Chip Revenue Market Share by Manufacturer in 2024
Figure 24. Global Cardiac-on-a-Chip Sales Market Share by Type (2020-2031)
Figure 25. Global Cardiac-on-a-Chip Revenue Market Share by Type (2020-2031)
Figure 26. Global Cardiac-on-a-Chip Sales Market Share by Application (2020-2031)
Figure 27. Global Cardiac-on-a-Chip Revenue Market Share by Application (2020-2031)
Figure 28. North America Cardiac-on-a-Chip Sales YoY (2020-2031) & (K Units)
Figure 29. North America Cardiac-on-a-Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Cardiac-on-a-Chip Sales Revenue (US$ Million) in 2024
Figure 31. North America Cardiac-on-a-Chip Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Cardiac-on-a-Chip Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Cardiac-on-a-Chip Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Cardiac-on-a-Chip Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Cardiac-on-a-Chip Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Cardiac-on-a-Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Cardiac-on-a-Chip Sales Revenue (US$ Million) in 2024
Figure 41. Europe Cardiac-on-a-Chip Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Cardiac-on-a-Chip Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Cardiac-on-a-Chip Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Cardiac-on-a-Chip Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 46. France Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Cardiac-on-a-Chip Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Cardiac-on-a-Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Cardiac-on-a-Chip Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Cardiac-on-a-Chip Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Cardiac-on-a-Chip Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Cardiac-on-a-Chip Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Cardiac-on-a-Chip Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 61. India Cardiac-on-a-Chip Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Cardiac-on-a-Chip Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Cardiac-on-a-Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Cardiac-on-a-Chip Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Cardiac-on-a-Chip Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Cardiac-on-a-Chip Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Cardiac-on-a-Chip Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Cardiac-on-a-Chip Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Cardiac-on-a-Chip Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Cardiac-on-a-Chip Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Cardiac-on-a-Chip Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Cardiac-on-a-Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Cardiac-on-a-Chip Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Cardiac-on-a-Chip Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Cardiac-on-a-Chip Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Cardiac-on-a-Chip Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Cardiac-on-a-Chip Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Cardiac-on-a-Chip Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Cardiac-on-a-Chip Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Cardiac-on-a-Chip Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Cardiac-on-a-Chip Revenue (2020-2025) & (US$ Million)
Figure 82. Cardiac-on-a-Chip Industry Chain Mapping
Figure 83. Regional Cardiac-on-a-Chip Manufacturing Base Distribution (%)
Figure 84. Global Cardiac-on-a-Chip Production Market Share by Region (2020-2031)
Figure 85. Cardiac-on-a-Chip Production Process
Figure 86. Regional Cardiac-on-a-Chip Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
